1. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection

   • H. Chaumont
   • A. San-Galli
   • A. Lannuzel

   Letter to the Editors 12 June 2020 Pages: 3121 - 3127

   

2. Isolated post SARS-CoV-2 diplopia

   • Alice Faucher
   • Pierre-Antoine Rey
   • Bertrand Degos

   Letter to the Editors 12 June 2020 Pages: 3128 - 3129

   

3. Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study

   • Giordano Cecchetti
   • Marco Vabanesi
   • Massimo Filippi

   Letter to the Editors 15 June 2020 Pages: 3130 - 3134

   

4. Neurological involvement of coronavirus disease 2019: a systematic review

   • Malik Ghannam
   • Qasem Alshaer
   • Georgios Manousakis

   Review 19 June 2020 Pages: 3135 - 3153

   

5. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease

   • Renan Barros Domingues
   • Maria Cássia Mendes-Correa
   • Carlos Augusto Senne Soares

   Short Commentary 20 June 2020 Pages: 3154 - 3156

   

6. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient

   • Lucia Princiotta Cariddi
   • Payam Tabaee Damavandi
   • Maurizio Versino

   Letter to the Editors 24 June 2020 Pages: 3157 - 3160

   

7. Characteristics and clinical course of Covid-19 patients admitted with acute stroke

   • Lucio D’Anna
   • Joseph Kwan
   • Soma Banerjee

   Letter to the Editors 24 June 2020 Pages: 3161 - 3165

   

8. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2

   • Martina Bracaglia
   • Ilaria Naldi
   • Patrizia De Massis

   Letter to the Editors 25 June 2020 Pages: 3166 - 3168

9. Gait and postural disorders in parkinsonism: a clinical approach

   • Cecilia Raccagni
   • Jorik Nonnekes
   • Gregor K. Wenning

   Review Open access 22 May 2019 Pages: 3169 - 3176

   

10. Prognostic utility of serum 25-hydroxyvitamin D in patients with stroke: a meta-analysis

    • Hongyu Liu
    • Jiaoqi Wang
    • Zhongxin Xu

    Review 08 November 2019 Pages: 3177 - 3186

    

11. Clinical and pathological features in adult-onset NIID patients with cortical enhancement

    • Huiting Liang
    • Bo Wang
    • Daojun Hong

    Original Communication 13 June 2020 Pages: 3187 - 3198

    

12. Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: a systematic review and meta-analysis

    • Tobias Granberg
    • Thomas Moridi
    • Benjamin V. Ineichen

    Original Communication Open access 13 June 2020 Pages: 3199 - 3212

    

13. Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis

    • Dana Pourzinal
    • Ji Hyun J. Yang
    • Nadeeka N. Dissanayaka

    Original Communication 13 June 2020 Pages: 3213 - 3222

    

14. Mild traumatic brain injury recovery: a growth curve modelling analysis over 2 years

    • Ellen L. Carroll
    • Joanne G. Outtrim
    • Virginia F. J. Newcombe

    Original Communication Open access 13 June 2020 Pages: 3223 - 3234

    

15. Change over time in ability to perform activities of daily living in myotonic dystrophy type 1

    • Erik Landfeldt
    • Nikoletta Nikolenko
    • Hanns Lochmüller

    Original Communication Open access 15 June 2020 Pages: 3235 - 3242

    

16. Candesartan in migraine prevention: results from a retrospective real-world study

    • Roberta Messina
    • Carlo P. Lastarria Perez
    • Peter J. Goadsby

    Original Communication 15 June 2020 Pages: 3243 - 3247

17. Appropriate assessment method of ¹²³I-MIBG myocardial scintigraphy for the diagnosis of Lewy body diseases and idiopathic REM sleep behavior disorder

    • Kazuto Tsukita
    • Naoko Tachibana
    • Toshiaki Hamano

    Original Communication 16 June 2020 Pages: 3248 - 3257

    

18. The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis

    • Christian Lunetta
    • Cristina Moglia
    • and EDARAVALS Study Group

    Original Communication 17 June 2020 Pages: 3258 - 3267

    

19. Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis

    • Magdalena Kolanko
    • Zarni Win
    • Paresh Malhotra

    Original Communication Open access 18 June 2020 Pages: 3268 - 3273

    

20. Investigation of poststroke epilepsy (INPOSE) study: a multicenter prospective study for prediction of poststroke epilepsy

    • Shuichi Yamada
    • Ichiro Nakagawa
    • Hiroyuki Nakase

    Original Communication 19 June 2020 Pages: 3274 - 3281

    

21. Midlife alcohol consumption and longitudinal brain atrophy: the PREVENT-Dementia study

    • Michael J. Firbank
    • John T. O’Brien
    • Craig W. Ritchie

    Original Communication Open access 20 June 2020 Pages: 3282 - 3286

    

22. Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance

    • Nina L. van Faals
    • Iris Dekker
    • Mike P. Wattjes

    Original Communication 20 June 2020 Pages: 3287 - 3291

    

23. Features of intracranial hemorrhage in cerebral venous thrombosis

    • K. Afifi
    • G. Bellanger
    • V. Thijs

    Original Communication 22 June 2020 Pages: 3292 - 3298

    

24. Correction to: Features of intracranial hemorrhage in cerebral venous thrombosis

    • K. Afifi
    • G. Bellanger
    • V. Thijs

    Correction 12 August 2020 Pages: 3299 - 3300

25. Late-onset post-lesional paroxysmal hypothermia: a case series and literature review

    • Perrine Devic
    • Laure Peter-Derex
    • Syvain Rheims

    Original Communication 22 June 2020 Pages: 3301 - 3309

    

26. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases

    • Jochem Helleman
    • Esther T. Kruitwagen-van Reenen
    • Anita Beelen

    Original Communication Open access 23 June 2020 Pages: 3310 - 3318

    

27. “Myo-neuropathy” is commonly associated with mitochondrial tRNA^Lysine mutation

    • Kunqian Ji
    • Bing Zhao
    • Chuanzhu Yan

    Original Communication 23 June 2020 Pages: 3319 - 3328

    

28. Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort

    • Sarah M. Buchanan
    • Thomas D. Parker
    • Jonathan M. Schott

    Original Communication Open access 24 June 2020 Pages: 3329 - 3336

    

29. Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis

    • Adrian Budhram
    • Jeffrey W. Britton
    • Nicholas L. Zalewski

    Original Communication 24 June 2020 Pages: 3337 - 3342

    

30. Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223

    • Brian Steingo
    • Yaser Al Malik
    • the CAMMS223, CAMMS03409, and TOPAZ Investigators

    Original Communication Open access 24 June 2020 Pages: 3343 - 3353

    

31. Early cognitive and emotional outcome after stroke is independent of discharge destination

    • Jos P. L. Slenders
    • Daan P. J. Verberne
    • Caroline M. van Heugten

    Original Communication Open access 24 June 2020 Pages: 3354 - 3361

32. Relationship between stroke etiology and collateral status in anterior circulation large vessel occlusion

    • Eva Hassler
    • Markus Kneihsl
    • Thomas Gattringer

    Original Communication Open access 25 June 2020 Pages: 3362 - 3370

    

33. High diagnostic value of plasma Niemann-Pick type C biomarkers in adults with selected neurological and/or psychiatric disorders

    • Daniele Mandia
    • Marion Plaze
    • Yann Nadjar

    Original Communication 26 June 2020 Pages: 3371 - 3377

    

34. Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy

    • Richard K. Burt
    • Roumen Balabanov
    • Basil Sharrack

    Original Communication 27 June 2020 Pages: 3378 - 3391

    

35. Hemodynamic changes between different anatomically designed stents after carotid stenting: a prospective multicenter study

    • JianFeng Han
    • JianLin Liu
    • Lin Yang

    Original Communication 29 June 2020 Pages: 3392 - 3399

    

36. Subclinical affective and cognitive fluctuations in Parkinson's disease: a randomized double-blind double-dummy study of Oral vs. Intrajejunal Levodopa

    • Jaime Kulisevsky
    • Helena Bejr-Kasem
    • Javier Pagonabarraga

    Original Communication 30 June 2020 Pages: 3400 - 3410

    

37. Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease

    • Peter Hagell
    • Arja Höglund
    • Filip Bergquist

    Original Communication Open access 01 July 2020 Pages: 3411 - 3417

    

38. Corpus callosum infarction: radiological and histological findings

    • Stefano Gelibter
    • Angela Genchi
    • Massimo Filippi

    Letter to the Editors 17 September 2020 Pages: 3418 - 3420

    

39. Case report of a cervical myelomalacia caused by a thoracolumbar intradural disc herniation leading to intracranial hypotension

    • M. Ueberschaer
    • M. Patzig
    • J.-C. Tonn

    Letter to the Editors Open access 03 October 2020 Pages: 3421 - 3424

    

40. Functional positional eye and eyelid movements

    • Mohamed Mabrouk Mustafa
    • Harry Akram
    • Diego Kaski

    Short Commentary Open access 15 July 2020 Pages: 3425 - 3428

    

41. Neurological update: neuroimaging in dementia

    • Timothy Rittman

    Neurological Update Open access 07 July 2020 Pages: 3429 - 3435

42. Multiple sclerosis: early indicators of disease and assessing future risk

    • M. D. Willis
    • N. P. Robertson

    Journal club Open access 08 October 2020 Pages: 3436 - 3438

43. Henryk Nusbaum (1849–1937)

    • Jan Zamojski
    • Marcin Moskalewicz

    Pioneers in Neurology Open access 17 September 2019 Pages: 3439 - 3440